Earlier this week, the pharmaceutical companies Biogen and Eisai announced encouraging results from a clinical trial for patients with Alzheimer’s disease: a monoclonal antibody treatment, called lecanemab, reduced cognitive decline by 27% in people with early-stage Alzheimer’s compared with...

High- and low-income countries alike last week joined in pledging $14.25 billion to the Global Fund to Fight AIDS, Tuberculosis and Malaria, in the largest single fundraising push for global health. www.science.org/content/article/news-glance-earth-science-satellites-global-fund-s-haul-and-neptune-s-rings? Supporters said the sum was necessary to help...